SGI
VSTM icon

Summit Global Investments’s Verastem VSTM Stock Holding History

Summit Global Investments’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,058
Closed -$778K – 620
2021
Q3 		$778K Buy
+21,058
New +$774K 0.06% 248

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Global Investments's VSTM Position: Q4 2021 in Review

Summit Global Investments sold out of Verastem (VSTM) in Q4 2021, closing a stake of 21,058 shares — an estimated $778K sold.

Summit Global Investments first reported a position in VSTM in Q3 2021 and held it in 1 quarter. The position peaked at $778K in Q3 2021. 153 funds tracked by Wall St. Rank hold VSTM as of Q4 2021.

  • Summit Global Investments reported no remaining Verastem position as of Q4 2021 after selling out during the quarter.
  • Summit Global Investments sold 21,058 Verastem shares in Q4 2021, an estimated $778K.
  • Summit Global Investments first reported a position in Verastem in Q3 2021 and held it in 1 quarter.
  • Summit Global Investments's Verastem position peaked at $778K in Q3 2021.
  • 153 funds tracked by Wall St. Rank held Verastem as of Q4 2021.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.